Japan Pharma Market Shrivels 5.1% on COVID-19 Crisis in July-Sept.: IQVIA

November 18, 2020
The Japanese ethical drug market in July-September 2020 shrunk 5.1% year on year to 2.53 trillion yen due to drug price cuts in April and fewer hospital visits by patients amid the COVID-19 pandemic, following a decrease seen in the...read more